Souhaitez-vous accéder aux communiqués récents ?

AMD Reimagines Tech Keynote at CES 2026 With an AI-Powered, Immersive Experience

RetinalGenix’s core thesis—that combining high‑resolution imaging, genetics, and advanced analytics may unlock new insights into ocular and systemic health

Generated Meaningful Portfolio Liquidity and Distributed Capital During 2025 Committed $20.0 Million to TensorWave Investment Expanding Exposure to AI Infrastructure NEW YORK, Jan. 12, 2026 (GLOBE...

SANTA CLARA, Calif., Jan. 06, 2026 (GLOBE NEWSWIRE) -- AMD (NASDAQ: AMD) announced today that it will report fiscal fourth quarter and full year 2025 financial results on Tuesday, Feb. 3, 2026,...

News Highlights AMD provided an early look at its “Helios” rack-scale platform, the blueprint for yotta-scale AI infrastructure, built on AMD Instinct MI455X GPUs and AMD EPYC “Venice” CPUs designed...

ASUS ROG marks 20 years at CES 2026, unveiling world-first tech, next-gen gaming systems, and bold collaborations redefining play

Numab to receive milestone payment Boehringer Ingelheim has advanced its novel multi-specific antibody for retinal diseases resulting from a collaboration with Numab into preclinical development ...

RetinalGenix signs agreement to hire M. Cory Zwerling as its chief financial officer and interim chief operating officer, effective January 1, 2026

News Highlights The Alice Recoque supercomputer will expand Europe’s AI, scientific computing and research capabilities while ensuring energy efficiency and sovereignty.Alice Recoque will be powered...

Classiq announced a strategic up-round with participation from AMD Ventures, Qualcomm Ventures, IonQ, Mirae Asset Capital, LeumiTech77 and Quantum Eretz.